Company profile for VelosBio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

VelosBio is a clinical-stage biopharmaceutical company committed to developing novel, first-in-class, ROR1-directed therapeutics to transform the lives of patients with cancer.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
11045 Roselle Street, Suite 130 San Diego CA 92121
Telephone
Telephone
+1 (858) 461-6666
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
Merck acquires VelosBio: exploring the promise of ROR1 in cancer
Merck acquires VelosBio: exploring the promise of ROR1 in cancer

19 Nov 2020

// Allie Nawrat PHARMACEUTICAL TECHNOLOGY

https://www.pharmaceutical-technology.com/features/merck-velosbio-ror1-cancer/

Allie Nawrat PHARMACEUTICAL TECHNOLOGY
19 Nov 2020

https://in.reuters.com/article/us-merck-co-deals/merck-to-bolster-cancer-drug-portfolio-with-velosbio-2-75-billion-deal-idINKBN27L1G8

Ankur Banerjee REUTERS
06 Nov 2020

https://www.biospace.com/article/releases/velosbio-announces-first-patient-dosed-in-phase-2-trial-of-vls-101-in-solid-tumors-/

BIOSPACE
19 Oct 2020

https://www.businesswire.com/news/home/20200831005097/en/VelosBio-Announces-FDA-Fast-Track-Orphan-Drug

BUSINESSWIRE
31 Aug 2020

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty